ID   FADS1_HUMAN             Reviewed;         444 AA.
AC   O60427; A8K0I7; B2RAI0; Q53GM5; Q8N3A6; Q8NCC7; Q8NCG0; Q96I39;
AC   Q96SV3; Q96T10; Q9NRP8; Q9NYX1;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-DEC-2013, sequence version 3.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=Fatty acid desaturase 1;
DE            EC=1.14.19.-;
DE   AltName: Full=Delta(5) fatty acid desaturase;
DE            Short=D5D;
DE            Short=Delta(5) desaturase;
DE            Short=Delta-5 desaturase;
GN   Name=FADS1; Synonyms=FADSD5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10601301; DOI=10.1074/jbc.274.52.37335;
RA   Cho H.P., Nakamura M., Clarke S.D.;
RT   "Cloning, expression, and fatty acid regulation of the human Delta-5
RT   desaturase.";
RL   J. Biol. Chem. 274:37335-37339(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=10769175; DOI=10.1042/bj3470719;
RA   Leonard A.E., Kelder B., Bobik E.G., Chuang L.-T., Parker-Barnes J.M.,
RA   Thurmond J.M., Kroeger P.E., Kopchick J.J., Huang Y.-S., Mukerji P.;
RT   "cDNA cloning and characterization of human Delta5-desaturase involved
RT   in the biosynthesis of arachidonic acid.";
RL   Biochem. J. 347:719-724(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=10860662; DOI=10.1006/geno.2000.6196;
RA   Marquardt A., Stoehr H., White K., Weber B.H.;
RT   "cDNA cloning, genomic structure, and chromosomal localization of
RT   three members of the human fatty acid desaturase family.";
RL   Genomics 66:175-183(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, Neuroblastoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney epithelium;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-272.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SUBCELLULAR LOCATION (ISOFORM 1), AND INDUCTION.
RX   PubMed=22619218; DOI=10.1194/jlr.M025312;
RA   Park W.J., Kothapalli K.S., Reardon H.T., Lawrence P., Qian S.B.,
RA   Brenna J.T.;
RT   "A novel FADS1 isoform potentiates FADS2-mediated production of
RT   eicosanoid precursor fatty acids.";
RL   J. Lipid Res. 53:1502-1512(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   ACETYLATION AT MET-1.
RX   PubMed=25732826; DOI=10.1016/j.celrep.2015.01.053;
RA   Aksnes H., Van Damme P., Goris M., Starheim K.K., Marie M.,
RA   Stoeve S.I., Hoel C., Kalvik T.V., Hole K., Glomnes N., Furnes C.,
RA   Ljostveit S., Ziegler M., Niere M., Gevaert K., Arnesen T.;
RT   "An organellar nalpha-acetyltransferase, naa60, acetylates cytosolic N
RT   termini of transmembrane proteins and maintains Golgi integrity.";
RL   Cell Rep. 10:1362-1374(2015).
CC   -!- FUNCTION: Isoform 2 does not exhibit any catalytic activity toward
CC       20:3n-6, but it may enhance FADS2 activity (By similarity).
CC       Isoform 1 is a component of a lipid metabolic pathway that
CC       catalyzes biosynthesis of highly unsaturated fatty acids (HUFA)
CC       from precursor essential polyunsaturated fatty acids (PUFA)
CC       linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA)
CC       (18:3n-3). Catalyzes the desaturation of dihomo-gamma-linoleic
CC       acid (DHGLA) (20:3n-6) and eicosatetraenoic acid (20:4n-3) to
CC       generate arachidonic acid (AA) (20:4n-6) and eicosapentaenoic acid
CC       (EPA)(20:5n-3), respectively. {ECO:0000250,
CC       ECO:0000269|PubMed:10601301, ECO:0000269|PubMed:10769175}.
CC   -!- PATHWAY: Lipid metabolism; polyunsaturated fatty acid
CC       biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A4UVI1}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:A4UVI1}. Mitochondrion
CC       {ECO:0000269|PubMed:22619218}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:A4UVI1}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:A4UVI1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=FADS1CS;
CC         IsoId=O60427-1; Sequence=Displayed;
CC       Name=2; Synonyms=FADS1AT1;
CC         IsoId=O60427-2; Sequence=VSP_047521;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in
CC       liver, brain, adrenal gland and heart. Highly expressed in fetal
CC       liver and brain. {ECO:0000269|PubMed:10601301,
CC       ECO:0000269|PubMed:10769175, ECO:0000269|PubMed:10860662}.
CC   -!- INDUCTION: Strongly down-regulated upon differentiation in a
CC       neuroblastoma cell line (at protein level).
CC       {ECO:0000269|PubMed:22619218}.
CC   -!- DOMAIN: The histidine box domains may contain the active site
CC       and/or be involved in metal ion binding.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11182.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAC11229.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027427; BAB55103.1; -; mRNA.
DR   EMBL; AK027522; BAB55173.1; -; mRNA.
DR   EMBL; AK074754; BAC11182.1; ALT_INIT; mRNA.
DR   EMBL; AK074819; BAC11229.1; ALT_INIT; mRNA.
DR   EMBL; AK096275; BAG53244.1; -; mRNA.
DR   EMBL; AK289552; BAF82241.1; -; mRNA.
DR   EMBL; AK314199; BAG36877.1; -; mRNA.
DR   EMBL; AC004770; AAC23397.1; -; Genomic_DNA.
DR   EMBL; AP002380; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF084558; AAG23120.1; -; mRNA.
DR   EMBL; AL512760; CAC21679.1; -; mRNA.
DR   EMBL; AL834479; CAD39138.1; -; mRNA.
DR   EMBL; AK222906; BAD96626.1; -; mRNA.
DR   EMBL; BC007846; AAH07846.1; -; mRNA.
DR   EMBL; AF199596; AAF29378.1; -; mRNA.
DR   EMBL; AF226273; AAF70457.1; -; mRNA.
DR   RefSeq; NP_037534.3; NM_013402.4.
DR   UniGene; Hs.503546; -.
DR   ProteinModelPortal; O60427; -.
DR   SMR; O60427; -.
DR   BioGrid; 110180; 18.
DR   IntAct; O60427; 2.
DR   STRING; 9606.ENSP00000322229; -.
DR   BindingDB; O60427; -.
DR   ChEMBL; CHEMBL5840; -.
DR   DrugBank; DB00132; Alpha-Linolenic Acid.
DR   DrugBank; DB00159; Icosapent.
DR   SwissLipids; SLP:000000368; -.
DR   iPTMnet; O60427; -.
DR   PhosphoSitePlus; O60427; -.
DR   EPD; O60427; -.
DR   MaxQB; O60427; -.
DR   PaxDb; O60427; -.
DR   PeptideAtlas; O60427; -.
DR   PRIDE; O60427; -.
DR   DNASU; 3992; -.
DR   Ensembl; ENST00000433932; ENSP00000405087; ENSG00000149485. [O60427-2]
DR   Ensembl; ENST00000542506; ENSP00000441403; ENSG00000149485. [O60427-2]
DR   GeneID; 3992; -.
DR   KEGG; hsa:3992; -.
DR   UCSC; uc010rln.2; human. [O60427-1]
DR   CTD; 3992; -.
DR   DisGeNET; 3992; -.
DR   GeneCards; FADS1; -.
DR   GeneCards; MIR1908; -.
DR   HGNC; HGNC:3574; FADS1.
DR   HPA; HPA042705; -.
DR   MIM; 606148; gene.
DR   neXtProt; NX_O60427; -.
DR   OpenTargets; ENSG00000149485; -.
DR   PharmGKB; PA27973; -.
DR   eggNOG; KOG4232; Eukaryota.
DR   eggNOG; ENOG410XVSZ; LUCA.
DR   GeneTree; ENSGT00510000046574; -.
DR   HOGENOM; HOG000012997; -.
DR   HOVERGEN; HBG002839; -.
DR   InParanoid; O60427; -.
DR   KO; K10224; -.
DR   PhylomeDB; O60427; -.
DR   TreeFam; TF313604; -.
DR   BioCyc; MetaCyc:HS07617-MONOMER; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   UniPathway; UPA00658; -.
DR   ChiTaRS; FADS1; human.
DR   GeneWiki; FADS1; -.
DR   GenomeRNAi; 3992; -.
DR   PRO; PR:O60427; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000149485; -.
DR   ExpressionAtlas; O60427; baseline and differential.
DR   Genevisible; O60427; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0000248; F:C-5 sterol desaturase activity; TAS:ProtInc.
DR   GO; GO:0045485; F:omega-6 fatty acid desaturase activity; TAS:Reactome.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0007267; P:cell-cell signaling; NAS:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; IDA:UniProtKB.
DR   GO; GO:0046456; P:icosanoid biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; TAS:Reactome.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.10.120.10; -; 1.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR012171; Fatty_acid_desaturase.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   PIRSF; PIRSF015921; FA_sphinglp_des; 1.
DR   PRINTS; PR00363; CYTOCHROMEB5.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; SSF55856; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Electron transport; Endoplasmic reticulum; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Mitochondrion; Oxidoreductase; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    444       Fatty acid desaturase 1.
FT                                /FTId=PRO_0000307096.
FT   TOPO_DOM      1    121       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical. {ECO:0000255}.
FT   TOPO_DOM    143    145       Lumenal. {ECO:0000255}.
FT   TRANSMEM    146    170       Helical. {ECO:0000255}.
FT   TOPO_DOM    171    267       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    268    288       Helical. {ECO:0000255}.
FT   TOPO_DOM    289    305       Lumenal. {ECO:0000255}.
FT   TRANSMEM    306    326       Helical. {ECO:0000255}.
FT   TOPO_DOM    327    444       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       17     94       Cytochrome b5 heme-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00279}.
FT   MOTIF       179    183       Histidine box-1.
FT   MOTIF       216    220       Histidine box-2.
FT   MOTIF       382    386       Histidine box-3.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:25732826}.
FT   VAR_SEQ       1     84       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047521.
FT   VARIANT     272    272       P -> S (in dbSNP:rs17856235).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_035340.
FT   CONFLICT      6      6       V -> L (in Ref. 7; AAF29378).
FT                                {ECO:0000305}.
FT   CONFLICT      9      9       E -> G (in Ref. 1; BAB55103).
FT                                {ECO:0000305}.
FT   CONFLICT     15     15       P -> L (in Ref. 7; AAF29378).
FT                                {ECO:0000305}.
FT   CONFLICT    100    100       F -> L (in Ref. 1; BAC11182).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       D -> E (in Ref. 1; BAC11182).
FT                                {ECO:0000305}.
FT   CONFLICT    180    180       D -> G (in Ref. 5; BAD96626).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       W -> R (in Ref. 1; BAB55173).
FT                                {ECO:0000305}.
FT   CONFLICT    213    213       N -> S (in Ref. 1; BAC11182).
FT                                {ECO:0000305}.
FT   CONFLICT    255    255       K -> N (in Ref. 7; AAF29378).
FT                                {ECO:0000305}.
FT   CONFLICT    319    319       F -> L (in Ref. 1; BAB55103).
FT                                {ECO:0000305}.
FT   CONFLICT    361    361       Q -> L (in Ref. 8; AAF70457).
FT                                {ECO:0000305}.
FT   CONFLICT    381    381       F -> S (in Ref. 1; BAC11229).
FT                                {ECO:0000305}.
FT   CONFLICT    410    410       H -> R (in Ref. 8; AAF70457).
FT                                {ECO:0000305}.
FT   CONFLICT    431    431       K -> E (in Ref. 1; BAC11229).
FT                                {ECO:0000305}.
SQ   SEQUENCE   444 AA;  51964 MW;  CC3C28D82AA49BF2 CRC64;
     MAPDPVAAET AAQGPTPRYF TWDEVAQRSG CEERWLVIDR KVYNISEFTR RHPGGSRVIS
     HYAGQDATDP FVAFHINKGL VKKYMNSLLI GELSPEQPSF EPTKNKELTD EFRELRATVE
     RMGLMKANHV FFLLYLLHIL LLDGAAWLTL WVFGTSFLPF LLCAVLLSAV QAQAGWLQHD
     FGHLSVFSTS KWNHLLHHFV IGHLKGAPAS WWNHMHFQHH AKPNCFRKDP DINMHPFFFA
     LGKILSVELG KQKKKYMPYN HQHKYFFLIG PPALLPLYFQ WYIFYFVIQR KKWVDLAWMI
     TFYVRFFLTY VPLLGLKAFL GLFFIVRFLE SNWFVWVTQM NHIPMHIDHD RNMDWVSTQL
     QATCNVHKSA FNDWFSGHLN FQIEHHLFPT MPRHNYHKVA PLVQSLCAKH GIEYQSKPLL
     SAFADIIHSL KESGQLWLDA YLHQ
//
